Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Status: Enrolling
Updated:  11/1/2017
William Beaumont Hemodialysis Units
mi
from
Royal Oak, MI
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Status: Enrolling
Updated: 11/1/2017
William Beaumont Hemodialysis Units
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Text Messages and Blood Pressure Control
Hypertension Control Using Bi-directional Texting for Home Blood Pressure Monitoring
Status: Enrolling
Updated:  11/1/2017
University of Iowa
mi
from
Iowa City, IA
Text Messages and Blood Pressure Control
Hypertension Control Using Bi-directional Texting for Home Blood Pressure Monitoring
Status: Enrolling
Updated: 11/1/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
Evaluation of a Community Health Worker Intervention on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
Status: Enrolling
Updated:  11/2/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
Evaluation of a Community Health Worker Intervention on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
Status: Enrolling
Updated: 11/2/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Risk Assessment of Long-Haul Truck Drivers
Risk Assessment of Long-Haul Truck Drivers
Status: Enrolling
Updated:  11/3/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Risk Assessment of Long-Haul Truck Drivers
Risk Assessment of Long-Haul Truck Drivers
Status: Enrolling
Updated: 11/3/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Non-invasive Blood Pressure (BP) Monitoring Compared to A-Line BP Monitoring
Accuracy and Precision of Oscillometric Blood Pressure Monitoring in the Arm, Calf and Thighs of Medical ICU Patients When Compared to Invasive Arterial Blood Pressure Monitoring
Status: Enrolling
Updated:  11/6/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Non-invasive Blood Pressure (BP) Monitoring Compared to A-Line BP Monitoring
Accuracy and Precision of Oscillometric Blood Pressure Monitoring in the Arm, Calf and Thighs of Medical ICU Patients When Compared to Invasive Arterial Blood Pressure Monitoring
Status: Enrolling
Updated: 11/6/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/7/2017
Children'S Hospital
mi
from
Aurora, CO
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/7/2017
Children'S Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/7/2017
Columbia University Medical Center Children's Hospital of New York Presbyterian - Site 9101
mi
from
New York, NY
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/7/2017
Columbia University Medical Center Children's Hospital of New York Presbyterian - Site 9101
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/7/2017
Texas Children's Hospital - Department of Cardiology - Site 9107
mi
from
Houston, TX
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/7/2017
Texas Children's Hospital - Department of Cardiology - Site 9107
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/7/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/7/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/7/2017
Royal Children's Hospital Melbourne, Cardiology - Site 5001
mi
from
Parkville,
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/7/2017
Royal Children's Hospital Melbourne, Cardiology - Site 5001
mi
from
Parkville,
Click here to add this to my saved trials
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/7/2017
Childrens National Medical Center
mi
from
Washington,
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/7/2017
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery: A Randomized, Single-Blinded Study
Status: Enrolling
Updated:  11/8/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery: A Randomized, Single-Blinded Study
Status: Enrolling
Updated: 11/8/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/9/2017
Children'S Hospital
mi
from
Aurora, CO
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/9/2017
Children'S Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/9/2017
Columbia University Medical Center Children's Hospital of New York Presbyterian - Site 9101
mi
from
New York, NY
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/9/2017
Columbia University Medical Center Children's Hospital of New York Presbyterian - Site 9101
mi
from
New York, NY
Click here to add this to my saved trials
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/9/2017
Texas Children's Hospital - Department of Cardiology - Site 9107
mi
from
Houston, TX
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/9/2017
Texas Children's Hospital - Department of Cardiology - Site 9107
mi
from
Houston, TX
Click here to add this to my saved trials
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/9/2017
Seattle Children's Hospital
mi
from
Seattle, WA
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/9/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/9/2017
Royal Children's Hospital Melbourne, Cardiology - Site 5001
mi
from
Parkville,
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/9/2017
Royal Children's Hospital Melbourne, Cardiology - Site 5001
mi
from
Parkville,
Click here to add this to my saved trials
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/9/2017
Childrens National Medical Center
mi
from
Washington,
FUTURE 3 Study Extension
A Prospective, Multicenter, Open-label Extension of FUTURE 3 to Assess the Safety, Tolerability and Efficacy of the Pediatric Formulation of Bosentan Two Versus Three Times a Day in Children With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/9/2017
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Oral Nifedipine Versus Oral Labetalol
Comparison of Oral Nifedipine to Oral Labetolol for the Management of Severe Postpartum Hypertension
Status: Enrolling
Updated:  11/15/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Oral Nifedipine Versus Oral Labetalol
Comparison of Oral Nifedipine to Oral Labetolol for the Management of Severe Postpartum Hypertension
Status: Enrolling
Updated: 11/15/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Status: Enrolling
Updated:  11/16/2017
Internal Medicine Clinic North; University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Status: Enrolling
Updated: 11/16/2017
Internal Medicine Clinic North; University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Status: Enrolling
Updated:  11/16/2017
Remedy Drug
mi
from
Little Rock, AR
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Status: Enrolling
Updated: 11/16/2017
Remedy Drug
mi
from
Little Rock, AR
Click here to add this to my saved trials
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Status: Enrolling
Updated:  11/16/2017
Internal Medicine Clinic West; University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
Status: Enrolling
Updated: 11/16/2017
Internal Medicine Clinic West; University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
University of Southern California
mi
from
Los Angeles, CA
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
Kansas University Medical Center
mi
from
Kansas City, KA
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
The University of Kansas School of Medicine, Wichita Via Christi Regional Medical Center
mi
from
Kansas City, KA
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
The University of Kansas School of Medicine, Wichita Via Christi Regional Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
Massachusetts General/Brigham Women's Hospital
mi
from
Boston, MA
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Massachusetts General/Brigham Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
Clinical Coordinating Center: University of Minnesota, Fairview Hospital
mi
from
Minneapolis, MN
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Clinical Coordinating Center: University of Minnesota, Fairview Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
JFK Medical Center
mi
from
Edison, NJ
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
JFK Medical Center
mi
from
Edison, NJ
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
Columbia University Medical Center
mi
from
New York, NY
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
Ohio State University
mi
from
Columbus, OH
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
Statistical Coordinating Center: Medical University of South Carolina
mi
from
Charleston, SC
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Statistical Coordinating Center: Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
Saint Louis University
mi
from
Saint Louis, MO
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Saint Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Emergency Department Home Blood Pressure Monitoring and BpTRU Study
Congruence of Emergency Department Attendings' Predictions of Hypertension With Results of Home Blood Pressure Monitoring
Status: Enrolling
Updated:  11/27/2017
Rhode Island Hospital
mi
from
Providence, RI
Emergency Department Home Blood Pressure Monitoring and BpTRU Study
Congruence of Emergency Department Attendings' Predictions of Hypertension With Results of Home Blood Pressure Monitoring
Status: Enrolling
Updated: 11/27/2017
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
A Phase II Multi-center, Randomized Study to Evaluate the Monocular Addition of Trabodenoson (INO-8875) Ophthalmic Formulation to Latanoprost Ophthalmic Solution Therapy in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated:  11/28/2017
Chiltern
mi
from
Bristol, TN
A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
A Phase II Multi-center, Randomized Study to Evaluate the Monocular Addition of Trabodenoson (INO-8875) Ophthalmic Formulation to Latanoprost Ophthalmic Solution Therapy in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 11/28/2017
Chiltern
mi
from
Bristol, TN
Click here to add this to my saved trials
Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks
Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks
Status: Enrolling
Updated:  12/4/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks
Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks
Status: Enrolling
Updated: 12/4/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management on High-Risk Pregnancy Outcomes
Status: Enrolling
Updated:  12/5/2017
Johns Hopkins Medical Institutions
mi
from
Baltimore, MD
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management on High-Risk Pregnancy Outcomes
Status: Enrolling
Updated: 12/5/2017
Johns Hopkins Medical Institutions
mi
from
Baltimore, MD
Click here to add this to my saved trials
DASH-Sodium Trial in Adolescents
DASH-Sodium Trial in Adolescents
Status: Enrolling
Updated:  12/6/2017
Department of Pediatrics, IU School of Medicine
mi
from
Indianapolis, IN
DASH-Sodium Trial in Adolescents
DASH-Sodium Trial in Adolescents
Status: Enrolling
Updated: 12/6/2017
Department of Pediatrics, IU School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
DASH-Sodium Trial in Adolescents
DASH-Sodium Trial in Adolescents
Status: Enrolling
Updated:  12/6/2017
Department of Nutrition Science Purdue University
mi
from
West Lafayette, IN
DASH-Sodium Trial in Adolescents
DASH-Sodium Trial in Adolescents
Status: Enrolling
Updated: 12/6/2017
Department of Nutrition Science Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Understanding Health Care Information for African Americans With High Blood Pressure
Promoting Health Literacy of African Americans With High Blood Pressure
Status: Enrolling
Updated:  12/7/2017
Johns Hopkins University
mi
from
Baltimore, MD
Understanding Health Care Information for African Americans With High Blood Pressure
Promoting Health Literacy of African Americans With High Blood Pressure
Status: Enrolling
Updated: 12/7/2017
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress
Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress
Status: Enrolling
Updated:  12/11/2017
University of Mississippi Medical Center
mi
from
Jackson, MS
Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress
Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress
Status: Enrolling
Updated: 12/11/2017
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/13/2017
University of South Alabama
mi
from
Mobile, AL
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/13/2017
University of South Alabama
mi
from
Mobile, AL
Click here to add this to my saved trials
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/13/2017
University of California San Diego Medical Center (La Jolla)
mi
from
La Jolla, CA
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/13/2017
University of California San Diego Medical Center (La Jolla)
mi
from
La Jolla, CA
Click here to add this to my saved trials
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/13/2017
GLVA Healthcare Center
mi
from
Los Angeles, CA
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/13/2017
GLVA Healthcare Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/13/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/13/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/13/2017
University of California, Davis, UC Davis Medical Center
mi
from
Sacramento, CA
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/13/2017
University of California, Davis, UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/13/2017
LIU Center for Pulmonary Hypertension
mi
from
Torrance, CA
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/13/2017
LIU Center for Pulmonary Hypertension
mi
from
Torrance, CA
Click here to add this to my saved trials
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/13/2017
Lung Health & Sleep Emhancement Center, LLC
mi
from
Newark, DE
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/13/2017
Lung Health & Sleep Emhancement Center, LLC
mi
from
Newark, DE
Click here to add this to my saved trials
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/13/2017
Emory University School of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
mi
from
Atlanta, GA
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/13/2017
Emory University School of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials